Occudo Quantitative Strategies LP Biocept Inc Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.83 - $3.97 $52,438 - $113,760	-28,655 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.43 - $4.22 $79,960 - $98,376	-23,312 Reduced 44.86%	28,655 $104,000
Q3 2021 Nov 15, 2021	BUY	$3.39 - $4.34 $176,168 - $225,536	51,967 New	51,967 $208,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.94 $147,565 - $247,188	-31,132 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.31 - $6.16 $134,178 - $191,773	31,132 New	31,132 $138,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.